Page last updated: 2024-08-22

titanium and 4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide

titanium has been researched along with 4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, J; Fang, Z; Kang, Y; Li, C; Li, L; Lin, X; Liu, Q; Pu, R; Qin, A; Shao, S; Wu, Z; Yuan, G; Zhao, J1

Other Studies

1 other study(ies) available for titanium and 4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide

ArticleYear
Vx-11e protects against titanium-particle-induced osteolysis and osteoclastogenesis by supressing ERK activity.
    Biochemical and biophysical research communications, 2019, 07-05, Volume: 514, Issue:4

    Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Particle Size; Protective Agents; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Titanium

2019